Original Research

DOI: 10.4244/EIJ-D-24-00589

Fractional flow reserve- and intravascular ultrasound-guided strategies for intermediate coronary stenosis and low lesion complexity in patients with or without diabetes: a post hoc analysis of the randomised FLAVOUR trial

Sung Woo Cho1, MD, PhD; Jeehoon Kang2, MD; Jinlong Zhang3, MD, PhD; Xinyang Hu3, MD, PhD; Ji-won Hwang1, MD, PhD; Jae-Jin Kwak1, MD, PhD; Joo-Yong Hahn4, MD, PhD; Chang-Wook Nam5, MD, PhD; Bong-Ki Lee6, MD; Weon Kim7, MD; Jinyu Huang8, MD; Fan Jiang9, MD; Hao Zhou10, MD; Peng Chen11, MD; Lijiang Tang12, MD; Wenbing Jiang13, MD; Xiaomin Chen14, MD; Wenming He15, MD; Sung Gyun Ahn16, MD; Myeong-Ho Yoon17, MD; Ung Kim18, MD; Joo Myung Lee4, MD, PhD; Doyeon Hwang2, MD; You-Jeong Ki19, MD, PhD; Eun-Seok Shin20, MD, PhD; Hyo-Soo Kim1, MD, PhD; Seung-Jea Tahk17, MD, PhD; Jian’an Wang3, MD, PhD; Bon-Kwon Koo2, MD, PhD; Joon-Hyung Doh1, MD, PhD

Abstract

Background: A recent randomised trial demonstrated fractional flow reserve (FFR) guidance for percutaneous coronary intervention (PCI) was non-inferior to intravascular ultrasound (IVUS) guidance regarding clinical outcomes, with a lower frequency of PCI.

Aims: We sought to evaluate the prognosis of FFR versus IVUS guidance for PCI of intermediate coronary artery stenosis and low lesion complexity in diabetic and non-diabetic patients.

Methods: This study is a prespecified post hoc analysis from the FLAVOUR trial. The primary outcome was major adverse cardiac events (MACE) at 24 months, defined as a composite of death, myocardial infarction or any revascularisation. The secondary outcomes were target vessel failure (TVF) and each component of MACE and TVF at 24 months.

Results: Among 1,682 randomly assigned patients, 554 (32.9%) had diabetes, and the mean SYNTAX score was 8.64±6.03 at baseline. The FFR group had a lower PCI rate than the IVUS group in both diabetic (48.2% vs 69.1%; p<0.001) and non-diabetic (42.6% vs 63.3%; p<0.001) patients. At 24 months, there was no difference in the cumulative incidence of MACE between the FFR and the IVUS groups in either diabetic (9.3% vs 8.3%; p=0.90) or non-diabetic (7.5% vs 8.6%; p=0.50) patients. The cumulative incidence of TVF was also comparable between the FFR and the IVUS groups regardless of diabetic status.

Conclusions: In patients with intermediate coronary stenosis and low lesion complexity, regardless of diabetic status, FFR guidance had no significant differences in MACE or TVF with a lower frequency of PCI compared with IVUS guidance.

Sign in to read
the full article

Forgot your password?
No account yet?
Sign up for free!

Create my pcr account

Join us for free and access thousands of articles from EuroIntervention, as well as presentations, videos, cases from PCRonline.com

Volume 21 Number 3
Feb 3, 2025
Volume 21 Number 3
View full issue


Key metrics

Suggested by Cory

10.4244/EIJV16I14A204 Feb 19, 2021
Ischaemic risk stratification after deferral of revascularisation on the basis of fractional flow reserve
Echavarria-Pinto M and van de Hoef TP
free

Research correspondence

10.4244/EIJ-D-22-00755 May 12, 2023
Changes in post-PCI optimisation strategies with post-procedural FFR followed by IVUS
Neleman T et al
free

Clinical research

10.4244/EIJ-D-18-00913 Aug 29, 2019
Influence of target vessel on prognostic relevance of fractional flow reserve after coronary stenting
Hwang D et al
free
Trending articles
69.746

10.4244/EIJV13I12A217 Dec 8, 2017
Swimming against the tide: insights from the ORBITA trial
Al-Lamee R and Francis D
free
58.8

State-of-the-Art

10.4244/EIJ-D-24-00066 Apr 21, 2025
Management of complications after valvular interventions
Bansal A et al
free
57.6

State-of-the-Art

10.4244/EIJ-D-24-00386 Feb 3, 2025
Mechanical circulatory support for complex, high-risk percutaneous coronary intervention
Ferro E et al
free
38.75

State-of-the-Art

10.4244/EIJ-D-23-00912 Oct 7, 2024
Optical coherence tomography to guide percutaneous coronary intervention
Almajid F et al
free
15.85

State-of-the-Art

10.4244/EIJ-D-23-01050 Jul 15, 2024
Durability of transcatheter aortic valve implantation
Ternacle J et al
free
11.8

EXPERIMENTAL RESEARCH

10.4244/EIJ-D-17-00595 Jan 19, 2018
Videodensitometric quantification of paravalvular regurgitation of a transcatheter aortic valve: in vitro validation
Abdelghani M et al
free
X

The Official Journal of EuroPCR and the European Association of Percutaneous Cardiovascular Interventions (EAPCI)

EuroPCR EAPCI
PCR ESC
Impact factor: 7.6
2023 Journal Citation Reports®
Science Edition (Clarivate Analytics, 2024)
Online ISSN 1969-6213 - Print ISSN 1774-024X
© 2005-2025 Europa Group - All rights reserved